Tamsulosin: an overview

C Chapple; Karl-Erik Andersson

doi:10.1007/s00345-002-0246-7

Tamsulosin: an overview

C Chapple, Karl-Erik Andersson

Division of Clinical Chemistry and Pharmacology

Research output: Contribution to journal › Article › peer-review

Abstract

This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent. Currently, there are no adequate studies that effectively compare existing agents for the treatment of benign prostatic hyperplasia using a randomised, placebo-controlled design with adequate numbers and this needs to be addressed in future studies.

Original language	English
Pages (from-to)	397-404
Journal	World Journal of Urology
Volume	19
Issue number	6
DOIs	https://doi.org/10.1007/s00345-002-0246-7
Publication status	Published - 2002

Subject classification (UKÄ)

Clinical Medicine

Free keywords

benign prostatic hyperplasia
pharmacotherapy
alpha antagonists

Access to Document

10.1007/s00345-002-0246-7

Cite this

@article{8c910f35e79d43b49b4b05bc5a984074,

title = "Tamsulosin: an overview",

abstract = "This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent. Currently, there are no adequate studies that effectively compare existing agents for the treatment of benign prostatic hyperplasia using a randomised, placebo-controlled design with adequate numbers and this needs to be addressed in future studies.",

keywords = "benign prostatic hyperplasia, pharmacotherapy, alpha antagonists",

author = "C Chapple and Karl-Erik Andersson",

year = "2002",

doi = "10.1007/s00345-002-0246-7",

language = "English",

volume = "19",

pages = "397--404",

journal = "World Journal of Urology",

issn = "1433-8726",

publisher = "Springer",

number = "6",

}

TY - JOUR

T1 - Tamsulosin: an overview

AU - Chapple, C

AU - Andersson, Karl-Erik

PY - 2002

Y1 - 2002

N2 - This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent. Currently, there are no adequate studies that effectively compare existing agents for the treatment of benign prostatic hyperplasia using a randomised, placebo-controlled design with adequate numbers and this needs to be addressed in future studies.

AB - This article reviews the contemporary literature related to tamsulosin, which is now the most widely used alpha antagonist in treating benign prostatic hyperplasia. The primary emphasis of this article is on the clinical data that exist related to this agent. Currently, there are no adequate studies that effectively compare existing agents for the treatment of benign prostatic hyperplasia using a randomised, placebo-controlled design with adequate numbers and this needs to be addressed in future studies.

KW - benign prostatic hyperplasia

KW - pharmacotherapy

KW - alpha antagonists

U2 - 10.1007/s00345-002-0246-7

DO - 10.1007/s00345-002-0246-7

M3 - Article

SN - 1433-8726

VL - 19

SP - 397

EP - 404

JO - World Journal of Urology

JF - World Journal of Urology

IS - 6

ER -

Tamsulosin: an overview

Abstract

Subject classification (UKÄ)

Free keywords

Access to Document

Fingerprint

Cite this